Pregnant women, their male partners and health care providers' perceptions of HIV self-testing in Kampala, Uganda: Implications for integration in prevention of mother-to-child transmission programs and scale-up.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 02 12 2020
accepted: 08 06 2021
entrez: 29 6 2021
pubmed: 30 6 2021
medline: 18 11 2021
Statut: epublish

Résumé

HIV status awareness is critical for HIV prevention and care but HIV testing rates remain low in Uganda, especially among men. One suggested approach to increase access and utilisation of HIV testing services is HIV self-testing. We explored perceptions of pregnant and lactating women and their male partners who attended antenatal care, and health care providers in a government hospital in Kampala, Uganda, about HIV self-testing for initial or repeat testing for women and their partners during pregnancy and postpartum We draw implications for scaling-up this new testing approach in Uganda. This was a qualitative study conducted at Mulago National Referral Hospital, Kampala, Uganda, between April and December 2017. We conducted in-depth interviews with five pregnant or lactating women and their five male partners; five focus group discussions (two with women, two with health workers and one with male partners of women attending antenatal care) and five key informant interviews with health workers providing prevention of mother-to-child HIV transmission (PMTCT) services. Data were analysed using content thematic approach. There was limited awareness about HIV self-testing especially among pregnant or lactating women and their male partners. Study participants mentioned that HIV self-testing would enable people to know their HIV status faster, they thought the approach would be cost- and time-saving compared to health facility-based HIV testing, improve confidentiality and reduce stigma for those who test HIV positive. They expressed however, a general fear that HIV self-testing would lead to harm to self and others in case one tested HIV positive, including suicide, violence among couples, intentional transmission of HIV, and limited linkage to care due to lack of counselling. The likely misinterpretation of HIV test results especially among those with no or limited education, and possible coercion exerted by male partners on their wives were other potential concerns raised about the use of HIV self-testing. There was limited knowledge about HIV self-testing among pregnant and lactating women, their partners and health workers. While the self-testing modality was perceived to be critical for helping people, especially those in casual and distant relationships, to know their HIV status and that of their partners, most study participants believed that HIV self-testing could potentially result in a multitude of negative outcomes in the absence of pre- and post-test counselling. Successful scale-up and integration of self-testing in HIV programs requires community education, provision of information materials and making self-test kits accessible and affordable, especially in rural areas.

Sections du résumé

BACKGROUND
HIV status awareness is critical for HIV prevention and care but HIV testing rates remain low in Uganda, especially among men. One suggested approach to increase access and utilisation of HIV testing services is HIV self-testing. We explored perceptions of pregnant and lactating women and their male partners who attended antenatal care, and health care providers in a government hospital in Kampala, Uganda, about HIV self-testing for initial or repeat testing for women and their partners during pregnancy and postpartum We draw implications for scaling-up this new testing approach in Uganda.
METHODS
This was a qualitative study conducted at Mulago National Referral Hospital, Kampala, Uganda, between April and December 2017. We conducted in-depth interviews with five pregnant or lactating women and their five male partners; five focus group discussions (two with women, two with health workers and one with male partners of women attending antenatal care) and five key informant interviews with health workers providing prevention of mother-to-child HIV transmission (PMTCT) services. Data were analysed using content thematic approach.
RESULTS
There was limited awareness about HIV self-testing especially among pregnant or lactating women and their male partners. Study participants mentioned that HIV self-testing would enable people to know their HIV status faster, they thought the approach would be cost- and time-saving compared to health facility-based HIV testing, improve confidentiality and reduce stigma for those who test HIV positive. They expressed however, a general fear that HIV self-testing would lead to harm to self and others in case one tested HIV positive, including suicide, violence among couples, intentional transmission of HIV, and limited linkage to care due to lack of counselling. The likely misinterpretation of HIV test results especially among those with no or limited education, and possible coercion exerted by male partners on their wives were other potential concerns raised about the use of HIV self-testing.
CONCLUSIONS
There was limited knowledge about HIV self-testing among pregnant and lactating women, their partners and health workers. While the self-testing modality was perceived to be critical for helping people, especially those in casual and distant relationships, to know their HIV status and that of their partners, most study participants believed that HIV self-testing could potentially result in a multitude of negative outcomes in the absence of pre- and post-test counselling. Successful scale-up and integration of self-testing in HIV programs requires community education, provision of information materials and making self-test kits accessible and affordable, especially in rural areas.

Identifiants

pubmed: 34185799
doi: 10.1371/journal.pone.0253616
pii: PONE-D-20-37894
pmc: PMC8241041
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0253616

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD070767
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH109337
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interferents exist.

Références

BMC Public Health. 2019 Oct 15;19(1):1289
pubmed: 31615461
Lancet HIV. 2021 Apr;8(4):e225-e236
pubmed: 33794183
PLoS One. 2017 Aug 16;12(8):e0183280
pubmed: 28813527
J Int AIDS Soc. 2015 Mar 20;18:19445
pubmed: 25797344
Diagnostics (Basel). 2020 May 19;10(5):
pubmed: 32438594
J Int AIDS Soc. 2012;15(2):17429
pubmed: 22905360
AIDS Behav. 2014 Dec;18(12):2477-84
pubmed: 24691923
AIDS Behav. 2014 Jul;18 Suppl 4:S396-404
pubmed: 24929834
BMC Health Serv Res. 2013 May 24;13:189
pubmed: 23705793
Curr Opin Infect Dis. 2018 Feb;31(1):14-24
pubmed: 29232277
BMC Public Health. 2019 Jan 11;19(1):53
pubmed: 30634943
Lancet. 2005 Oct 1;366(9492):1182-8
pubmed: 16198767
J Infect Dis. 2009 Sep 1;200(5):667-9
pubmed: 19627246
Pan Afr Med J. 2020 Oct 08;37:138
pubmed: 33425171
Int J STD AIDS. 2017 Nov;28(13):1341-1347
pubmed: 28449628
BMC Public Health. 2020 May 15;20(1):694
pubmed: 32414405
AIDS Behav. 2020 Nov;24(11):3006-3009
pubmed: 32451939
AIDS. 2009 Jun 19;23(10):1255-9
pubmed: 19455017
PLoS Med. 2014 Feb 25;11(2):e1001608
pubmed: 24586123
AIDS Behav. 2018 Feb;22(2):580-592
pubmed: 28540563
PLoS Med. 2011 Oct;8(10):e1001102
pubmed: 21990966
AIDS Behav. 2014 Jul;18 Suppl 4:S422-32
pubmed: 24947852
AIDS Behav. 2015 Nov;19(11):1949-65
pubmed: 26054390
PLoS Med. 2015 Sep 08;12(9):e1001873
pubmed: 26348035
AIDS Behav. 2014 Jul;18 Suppl 4:S405-14
pubmed: 24974123
J Acquir Immune Defic Syndr. 2020 Aug 1;84(4):365-371
pubmed: 32195747
J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):271-279
pubmed: 32168168
Pan Afr Med J. 2013 Jun 09;15:50
pubmed: 24106578
BMC Public Health. 2020 Jan 15;20(1):66
pubmed: 31941479
PLoS One. 2019 Feb 25;14(2):e0212119
pubmed: 30802277
Nurse Educ Today. 2004 Feb;24(2):105-12
pubmed: 14769454
Glob Health Action. 2018;11(1):1503784
pubmed: 30092155
J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25293
pubmed: 31321884
AIDS Behav. 2020 Nov;24(11):3014-3016
pubmed: 32488551
Lancet HIV. 2016 Jun;3(6):e266-74
pubmed: 27240789

Auteurs

Joseph Rujumba (J)

Department of Pediatrics and Child Health, College of Health Sciences, Makerere University, Kampala, Uganda.

Jaco Homsy (J)

Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, United States of America.

Femke Bannink Mbazzi (FB)

Faculty of Psychology and Educational Sciences, Ghent University, Ghent, Belgium.
The MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda.

Zikulah Namukwaya (Z)

Infectious Diseases Institutes, Makerere University Kampala, Kampala, Uganda.

Alexander Amone (A)

Makerere University -Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.

Gordon Rukundo (G)

Makerere University -Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.

Elly Katabira (E)

Makerere University -Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Department of Medicine & College of Health Sciences, Makerere University School of Medicine, Kampala, Uganda.

Josaphat Byamugisha (J)

Department of Obstetrics and Gynecology, Makerere University School of Medicine, Kampala, Uganda.

Mary Glenn Fowler (MG)

Makerere University -Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Department of Medicine, Johns Hopkins University, Baltimore, MD, United States of America.

Rachel L King (RL)

Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH